CMBT CMB TECH NV

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14D-9

(RULE 14d-101)

SOLICITATION/RECOMMENDATION STATEMENT

UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE ACT OF 1934

CMB.TECH NV

(Name of Subject Company)

CMB.TECH NV

(Name of Person(s) Filing Statement)

Ordinary shares, no par value

(Title of Class of Securities)

B38564108

(CUSIP Number of Class of Securities)

Seward & Kissel LLP

Attention: Keith Billotti, Esq.

One Battery Park Plaza

New York, New York 10004

(212) 574-1200

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications

on Behalf of the Person(s) Filing Statement)

With copies to

INTRODUCTION

This Solicitation/Recommendation Statement (this “Statement”) relates to a tender offer (the “U.S. Offer”) by Compagnie Maritime Belge NV, a public limited liability company (“naamloze vennootschap”) under Belgian law (“CMB” or the “Offeror”) in respect of the ordinary shares, no par value per share (“Ordinary Shares”), of CMB.TECH NV (formerly Euronav NV), a limited liability company incorporated under the laws of Belgium (“we,” “us,” “our,” “CMB.TECH,” or the “Company”).

CMB.TECH is the same company as Euronav NV. On October 1, 2024, the Company’s name was officially changed from “Euronav NV” to “CMB.TECH NV”. The trading symbol under which the Ordinary Shares trade on both the New York Stock Exchange (the “NYSE”) and Euronext Brussels was also changed from “EURN” to “CMBT” as of July 15, 2024.

CMB is making the U.S. Offer pursuant to the U.S. Offer to Purchase (as amended, the “U.S. Offer to Purchase”) that is included in its Tender Offer Statement on Schedule TO (“Schedule TO”) that it filed on October 23, 2024, with the Securities and Exchange Commission (the “SEC”). As part of the U.S. Offer, CMB is offering to pay $12.66 for each Ordinary Share, in cash, without interest and less any applicable withholding taxes (the “Offer Price”). The Offer Price will be reduced on a dollar-for-dollar basis by the gross amount of any distributions by the Company to its shareholders (including in the form of a dividend, distribution of share premium, decrease of share capital or in any other form) with a payment date falling after the date of the U.S. Offer to Purchase and before the Settlement Date (as defined below). For additional information, please see the U.S. Offer to Purchase, including “How much are you offering to pay for the Ordinary Shares and what is the form of payment?”

On November 22, 2023 CMB purchased 57,479,744 of the Company’s Ordinary Shares (the “Share Purchase”), representing 28.47% of the then outstanding Ordinary Shares, from Famatown Finance Limited (“Famatown”) and Frontline plc (“Frontline” and, together with Famatown, the “Sellers”), pursuant to a Share Purchase Agreement, dated October 9, 2023, between the Sellers and CMB (the “Share Purchase Agreement”). CMB conducted the Share Purchase at a price of $18.43 per share, or an aggregate of $1,059,351,682, in cash (the “Share Purchase”) and became the holder of more than 30% of the issued Ordinary Shares. The Company was not a party to the Share Purchase Agreement. As a result of the Share Purchase, CMB became obligated under Belgian law to make a mandatory, unconditional, public takeover bid on the remaining Ordinary Shares of the Company that were not already then owned by CMB or its affiliates. The takeover bid was launched in the United States and Belgium on February 14, 2024, the acceptance period expired on March 15, 2024 and the offers were consummated on April 3, 2024 (the “Completed Bid”). The bid price of the Completed Bid was based upon the purchase price in the Share Purchase of $18.43 per Ordinary Share (the “Original Reference Price”). The Offeror’s sole purpose in making the Completed Bid was to comply with its legal obligation to launch a public takeover bid in accordance with Belgian law. A total of 69,241,955 Ordinary Shares, representing 31.47% of the then-outstanding shares of the Company, were tendered to the Offeror in the Completed Bid, increasing its ownership of the Company to 87.60%.

In connection with the Completed Bid, certain funds managed by FourWorld Capital Management, LLC (“FourWorld”) filed a complaint with the Market Court in Belgium (the “Market Court”) on February 29, 2024 alleging, among other things, that the Original Reference Price did not reflect certain purported special benefits that FourWorld claimed had been granted to Frontline in addition to the price paid by CMB in the Share Purchase, and requested that the Market Court order CMB to adjust the Original Reference Price to account for these alleged special benefits. In its ruling dated September 6, 2024, the Market Court dismissed some of FourWorld’s claims as inadmissible and/or unfounded, but did find that the price at which certain vessels were sold by the Company to Frontline implied certain indirect special benefits to Frontline and calculated these indirect special benefits to be $0.52 per Ordinary Share. The Market Court ordered the Financial Services and Markets Authority of Belgium (the “FSMA”) to assess whether, in view of its finding that indirect special benefits were granted to Frontline amounting to $0.52 per share, the original bid price should be modified. On October 7, 2024, the FSMA decided to effectively require an increase in the Original Reference Price of $0.52 per Ordinary Share and ordered CMB, more specifically, to (i) pay $0.52 per share to all shareholders whose

Ordinary Shares were validly tendered in the Completed Bid and (ii) reopen the Completed Bid at an adjusted price which takes into account the Original Reference Price, increased by $0.52 per share (the “FSMA Order”). Taking into account the Original Reference Price, increased by $0.52, in accordance with the FSMA Order, and decreased by $6.29 (the aggregate amount of distributions made by the Company to its shareholders since the initial announcement of the Completed Bid on October 9, 2023), this results in an offer price per share of $12.66 (the “Offer Price”). The U.S. Offer to Purchase described in this Solicitation/Recommendation Statement is being made solely in order to comply with the FSMA Order.

The term “Settlement Date” means the date on which the Offer Price is paid to U.S. Holders who have tendered their Shares in the U.S. Offer and on which title to such Shares is transferred to the Offeror.

The term “U.S. Holders” has the meaning given it under instruction 2 to paragraphs (c) and (d) of Rule 14d-1 under the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Concurrently with the U.S. Offer, the Offeror is making an offer in Belgium to purchase all outstanding Ordinary Shares of the Company from all holders (other than the Offeror and its affiliates), wherever located, for the same price and on substantially the same terms as the U.S. Offer (the “Belgian Offer” and together with the U.S. Offer, the “Offers”).

The Company’s Supervisory Board (the “Supervisory Board”) unanimously recommends that holders of Ordinary Shares reject the Offers and NOT tender their Ordinary Shares in the Offers. The Supervisory Board reached the conclusion to recommend the Company’s shareholders reject the Offers and NOT tender their Ordinary Shares in the Offers because the Offer Price is below the trading price of the Ordinary Shares on October 21, 2024 and in view of the Company’s new strategy. While the Supervisory Board advises you to reject the Offers and stay invested in the Company, the Supervisory Board advises shareholders to consult their own financial, tax and legal advisors and make such other investigations concerning the Offers, including obtaining a current market price for the Ordinary Shares, as they deem necessary in order to make an informed decision with respect to the Offers.

The U.S. Offer to Purchase and the related documents contain important information that you should read before making any decision in connection with the U.S. Offer.

Item 1. Subject Company Information.

The Company’s name and the address and telephone number of its principal executive office is as follows:

CMB.TECH NV

De Gerlachekaai 20

2000 Antwerpen, Belgium

Tel: 0032 (0) 3 247 44 11

This Schedule 14D-9 relates to the Ordinary Shares. As of September 30, 2024, the Company had 220,024,713 Ordinary Shares issued, of which 25,807,878 were treasury shares and 194,216,835 were outstanding. The Offeror is conducting the Offers solely to comply with the FSMA Order.

Item 2. Identity and Background of Filing Person.

The Company is the person filing this Statement. The Company’s name, address and business telephone number are set forth in Item 1 above, which information is incorporated herein by reference.

This Schedule 14D-9 relates to the U.S. Offer pursuant to which the Offeror has offered to purchase, subject to certain terms and conditions, up to 8.78 % of the outstanding Ordinary Shares at the Offer Price.

According to the Schedule TO, the U.S. Offer commenced on October 23, 2024, and will expire at 10:00 A.M., New York City time, on November 21, 2024 the “Initial Expiration Date”. The U.S. Offer may be

extended as described in this Offer to Purchase. The Belgian Offer is currently scheduled to expire at 4:00 P.M., Brussels Belgium time (10:00 A.M., New York City time), on the Initial Expiration Date. If the Offeror makes a material change to the U.S. Offer to Purchase or any other information published or sent or given to shareholders in respect to the U.S. Offer, the Offeror may be required under U.S. law to extend the U.S. Offer by up to ten U.S. business days, meaning any day other than a Saturday, Sunday or a federal holiday in the U.S. In such case, the Offeror would also extend the Belgian Offer. Any extension of the Offers would be made by public announcement thereof, which will be made no later than 9:00 A.M., New York City time (3:00 P.M., Brussels, Belgium time), on the next U.S. business day after the previously scheduled expiration date. If the U.S. Offer is extended in accordance with U.S. law, the Offeror currently intends to extend the Belgian Offer so that it will expire on the same day as, and simultaneously with, the U.S. Offer.

All U.S. Holders of Ordinary Shares may tender their Ordinary Shares into either the U.S. Offer or the Belgian Offer. Non-U.S. Holders of Ordinary Shares may not tender their Ordinary Shares into the U.S. Offer.

According to the Schedule TO, the address for the Information Agent of the U.S. Offer is 1290 Avenue of the Americas, 9th Floor, New York, NY, 10104 and U.S. shareholders, banks and brokers can call the Information Agent toll free +1 888-815-4069 (outside U.S. and Canada can call +1 781-896-6948).

Item 3. Past Contacts, Transactions, Negotiations and Agreements

Shareholders should be aware that certain officers and directors of the Company have interests in the Offers, which are described in this Statement and which may present them with certain actual or potential conflicts of interest with respect to the Offer. This Item 3 contains information (either set forth below or incorporated herein by reference) regarding the interests of the Company’s directors and executive officers with respect to the Offers.

The Offeror is CMB, with registered office at De Gerlachekaai 20, 2000 Antwerp (with telephone number +32 3 247 59 11) registered in the Crossroads Bank of Enterprises with company number 0404.535.431 (RLE Antwerp, division Antwerp). The Offeror is a subsidiary of Saverco NV, a public limited liability company (“naamloze vennootschap”) under Belgian law (“Saverco”), which is an investment holding company. Saverco and CMB are privately held companies. Saverco owns 100% of the outstanding shares of CMB. Alexander Saverys, Ludovic Saverys and Michael Saverys each own approximately 33.33% of the issued shares of Saverco. None of these individuals own any shares of the Offeror directly. The Offeror is the largest shareholder of the Company. As of the date hereof, the Offeror owns 177,147,299 Ordinary Shares or approximately 91.21% of the outstanding Ordinary Shares, and Saverco owns 24,400 Ordinary Shares or approximately 0.01% of the outstanding Ordinary Shares. The Offeror has three representatives on the Company’s Supervisory Board, and the Chief Executive Offer and Chief Financial Officer of the Offeror are also the Chief Executive Officer and Chief Financial Officer of the Company, respectively. See Annex A to the U.S. Offer to Purchase for more information on the Board of Directors and executive officers of the Offeror.

As described above, certain of the directors and/or executive officers of the Company are also directors and/or executive officers of the Offeror or affiliates of the Offeror. The Offeror has indicated in the U.S. Offer to Purchase that it expects that such persons will retain their respective positions at the Company following completion of the Offers.

Supervisory Board Relationships

Management Relationships

Item 4. The Solicitation or Recommendation.

(a) Recommendation of the Supervisory Board

On behalf of the Company, the Supervisory Board reviewed the terms and conditions of the Offers with the assistance of its legal advisors.

THE SUPERVISORY BOARD UNANIMOUSLY RECOMMENDS THAT HOLDERS OF ORDINARY SHARES SHOULD REJECT THE OFFERS AND NOT TENDER THEIR ORDINARY SHARES IN THE OFFERS.

The Supervisory Board reached the conclusion to recommend holders of Ordinary Shares reject the Offers in light of the factors discussed below in “Reasons for the Recommendation.”

The Supervisory Board advises shareholders to consult their own financial, tax and legal advisors and make such other investigations concerning the Offers, including obtaining a current market price for the Ordinary Shares, as they deem necessary in order to make an informed decision with respect to the Offers.

(b) Background and Reasons for the Supervisory Board’s Position.

Background

On November 22, 2023 CMB purchased 57,479,744 of the Company’s Ordinary Shares (the “Share Purchase”), representing 28.47% of the then outstanding Ordinary Shares, from Famatown Finance Limited (“Famatown”) and Frontline plc (“Frontline” and, together with Famatown, the “Sellers”), pursuant to a Share Purchase Agreement, dated October 9, 2023, between the Sellers and CMB (the “Share Purchase Agreement”). CMB conducted the Share Purchase at a price of $18.43 per share, or an aggregate of $1,059,351,682, in cash (the “Share Purchase”) and became the holder of more than 30% of the issued Ordinary Shares. The Company was not a party to the Share Purchase Agreement. As a result of the Share Purchase, CMB became obligated under Belgian law to make a mandatory, unconditional, public takeover bid on the remaining Ordinary Shares of the Company that were not already then owned by CMB or its affiliates. The takeover bid was launched in the United States and Belgium on February 14, 2024, the acceptance period expired on March 15, 2024 and the offers were consummated on April 3, 2024 (the “Completed Bid”). The bid price of the Completed Bid was based upon the purchase price in the Share Purchase of $18.43 per Ordinary Share (the “Original Reference Price”). The Offeror’s sole purpose in making the Completed Bid was to comply with its legal obligation to launch a public takeover bid in accordance with Belgian law. A total of 69,241,955 Ordinary Shares, representing 31.47% of the then-outstanding shares of the Company, were tendered to the Offeror in the Completed Bid, increasing its ownership of the Company to 87.60%.

In connection with the Completed Bid, certain funds managed by FourWorld Capital Management, LLC (“FourWorld”) filed a complaint with the Market Court in Belgium (the “Market Court”) on February 29, 2024 alleging, among other things, that the Original Reference Price did not reflect certain purported special benefits that FourWorld claimed had been granted to Frontline in addition to the price paid by CMB in the Share Purchase, and requested that the Market Court order CMB to adjust the Original Reference Price to account for these alleged special benefits. In its ruling dated September 6, 2024, the Market Court dismissed some of FourWorld’s claims as inadmissible and/or unfounded, but did find that the price at which certain vessels were sold by the Company to Frontline implied certain indirect special benefits to Frontline and calculated these indirect special benefits to be $0.52 per Ordinary Share. The Market Court ordered the Financial Services and Markets Authority of Belgium (the “FSMA”) to assess whether, in view of its finding that indirect special benefits were granted to Frontline amounting to $0.52 per share, the original bid price should be modified. On October 7, 2024, the FSMA decided to effectively require an increase in the Original Reference Price of $0.52 per Ordinary Share and ordered CMB, more specifically, to (i) pay $0.52 per share to all shareholders whose Ordinary Shares were validly tendered in the Completed Bid and (ii) reopen the Completed Bid at an adjusted price which takes into account the Original Reference Price, increased by $0.52 per share (the “FSMA Order”). Taking into account the Original Reference Price, increased by $0.52, in accordance with the FSMA Order, and decreased by $6.29 (the aggregate amount of distributions made by the Company to its shareholders since the initial announcement of the Completed Bid on October 9, 2023), this results in an offer price per share of $12.66 (the “Offer Price”).

The Offers are being made solely to comply with the FSMA Order.

Reasons for the Recommendation

The following two factors constitute the reasons for the Supervisory Board’s determination to unanimously recommend that holders of Ordinary Shares reject the Offers and NOT tender their Ordinary Shares in the Offers.

According to the Schedule TO, the Offeror’s sole purpose in making the Offers is to comply with the FSMA Order to reopen its unconditional mandatory public takeover bid at the Offer Price for all Ordinary Shares of the Company that CMB and its affiliates do not already own in accordance with Belgian law. The Offeror does not intend to delist the Company from the NYSE or Euronext Brussels and, as such, does not intend to undertake a squeeze-out offer after the expiration of the Acceptance Period and consummation of the Offers. Following the closing of the Completed Bid, CMB continues to execute its strategy for the Company, which aims to make the Company the reference platform for sustainable shipping and is based on three axes: diversification of the Company’s fleet, decarbonization of the Company’s fleet, and optimization of the Company’s existing fleet. For more information on CMB’s plans for the Company, see the U.S. Offer to Purchase, including “Plans for the Company.”

Accordingly, the Supervisory Board expressed unanimously that holders of Ordinary Shares should reject the Offers and NOT tender their Ordinary Shares in the Offers. While the Supervisory Board advises you to reject the Offers and stay invested in the Company, the Supervisory Board advises shareholders to consult their own financial, tax and legal advisors and make such other investigations concerning the Offers, including obtaining a current market price for the Ordinary Shares, as they deem necessary in order to make an informed decision with respect to the Offers.

The foregoing discussion of the factors and reasons considered by the Supervisory Board is intended to be a summary, and is not exhaustive, but rather includes the principal factors and reasons considered by the Supervisory Board.

(c) Intent to Tender.

The Company’s directors and executive officers are entitled to participate in the Offers on the same basis as other shareholders. However, after reasonable inquiry and to the best knowledge of the Company, none of the directors or executive officers of the Company intends to tender or sell Ordinary Shares that they hold of record or beneficially pursuant to the Offers.

Item 5. Person/Assets, Retained, Employed, Compensated or Used.

Neither the Company nor any person acting on its behalf has employed, retained or agreed to compensate any person to make solicitations or recommendations to shareholders concerning the Offers.

Item 6. Interest in Securities of the Subject Company.

Based on the Company’s records and on information provided to the Company by its directors, executive officers, affiliates and subsidiaries, during the past 60 days no transactions with respect to the Ordinary Shares have been effected by the Company, or its executive officers, directors, affiliates or subsidiaries.

Item 7. Purposes of the Transaction and Plans or Proposals.

The Company has not undertaken and is not engaged in any negotiations in response to the Offers that relate to: (i) a tender offer or other acquisition of the securities of the Company or any of its subsidiaries by any other person; (ii) an extraordinary transaction, such as a merger, reorganization or liquidation involving the Company or any of its subsidiaries; (iii) a purchase, sale or transfer of a material amount of assets of the Company or any of its subsidiaries; or (iv) any material change in the present distribution rate or policy, or indebtedness or capitalization of the Company.

Additionally, there is no transaction, board resolution, agreement in principle, or signed contract in response to the Offers which relates to or would result in one or more of the foregoing matters.

Item 8. Additional Information.

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this Statement other than historical facts may be considered forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results or events to be materially different. The words “may,” “will,” “seeks,” “anticipates,” “believes,” “expects,” “estimates,” “projects,” “plans,” “intends,” “should” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to a number of risks, uncertainties and other factors, many of which are outside of the Company’s control, which could cause actual results to differ materially from the results contemplated by the forward-looking statements. These risks and uncertainties include among other things, to the following:

While the list of factors presented here is representative, no list should be considered a statement of all potential risks, uncertainties or assumptions that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements. The foregoing factors should be read in conjunction with the risks and cautionary statements discussed or identified in the public filings with the SEC made by the Company, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements and Risk Factor Summary” in the Company’s Annual Report on Form 20-F for the year ended December 31, 2023 filed on April 11, 2024 and all other filings with the SEC after that date, including but not limited to the subsequent Current Reports on Form 6-K, as such risks, uncertainties and other important factors may be updated from time to time in the Company’s subsequent reports.

The forward-looking statements contained in this Statement speak only as of the date of this Statement. The Company does not undertake any obligation to revise or update any forward-looking statements to reflect new information, future events or circumstances after the date of the forward-looking statement, unless required by law.

Item 9. Exhibits.

SIGNATURE

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.

Date: October 23, 2024

Exhibit (a)(8)

Regulated information

CMB NV LAUNCHES THE REOPENING OF ITS PUBLIC TAKEOVER

BID AND CONCURRENT NEW U.S. OFFER ON CMB.TECH NV

ANTWERP, Belgium, October 23, 2024, 7:30 a.m. CET – CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMB.TECH” or the “Company”) announces that today CMB NV (“CMB” or “the Bidder”) has (i) reopened its Belgian public takeover bid on all shares in CMB.TECH not already owned by CMB or persons affiliated with it, in accordance with applicable Belgian law, and (ii) concurrently is making a new U.S. offer in accordance with applicable U.S. federal securities laws (the “New U.S. Offer”), addressed to U.S. shareholders within the meaning of Rule 14d-1(d) under the Securities Exchange Act of 1934, as amended (together the “Reopening”).

The acceptance period of the Reopening opens on October 23, 2024 and closes on November 21, 2024 at 4 p.m. (CET) (10 a.m. New York City time). The bid price of the Reopening amounts to USD 12.66 per share, i.e. USD 18.95 per share (as increased) reduced by distributions totalling USD 6.29 per share.

In the supplement to its response memorandum, the supervisory board of CMB.TECH unanimously recommends that shareholders do not tender their shares in the Reopening.

The prospectus, the supplement to the prospectus (including the supplement to the response memorandum) and the acceptance forms of the Reopening are available on the following websites: CMB and KBC.

An offer to purchase has been filed on a form “Schedule TO” (and the company response will be included in the Schedule 14D-9 filing) with the SEC and can be accessed through the following website https://cmb.tech/investors/financial- information/sec-filings.

Read the more detailed press release of CMB NV here: www.cmb.be/mandatorybid.

About CMB.TECH

CMB.TECH (all capitals) is a diversified and future-proof maritime group that is a pioneer in decarbonising shipping. We own and operate more than 160 vessels: crude oil tankers, dry bulk vessels, container ships, chemical tankers, offshore wind ships, tugs and ferries. We also offer hydrogen and ammonia fuel to customers, through own production or third- party producers. The company is headquartered in Antwerp, Belgium, and has offices across Europe, Asia and Africa.

CMB.TECH is listed on Euronext Brussels and the NYSE under the ticker symbol CMBT. More information can be found at https://cmb.tech.

About CMB

CMB (Compagnie Maritime Belge) is a shipping group based in Antwerp, Belgium. CMB is the majority shareholder of CMB.TECH.

More information can be found at www.cmb.be.

Regulated information

Forward-Looking Statements

Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbour protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. The Company desires to take advantage of the safe harbour provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbour legislation. The words “believe”, “anticipate”, “intends”, “estimate”, “forecast”, “project”, “plan”, “potential”, “may”, “should”, “expect”, “pending” and similar expressions identify forward-looking statements.

The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections.

In addition to these important factors, other important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include the failure of counterparties to fully perform their contracts with us, the strength of world economies and currencies, general market conditions, including fluctuations in charter rates and vessel values, changes in demand for tanker vessel capacity, changes in our operating expenses, including bunker prices, dry-docking and insurance costs, the market for our vessels, availability of financing and refinancing, charter counterparty performance, ability to obtain financing and comply with covenants in such financing arrangements, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, potential disruption of shipping routes due to accidents or political events, vessels breakdowns and instances of off-hires and other factors. Please see our filings with the United States Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties.

Disclaimer

This press release is also published in Dutch. If ambiguities should arise from the different language versions, the Dutch version will prevail.

This notice does not constitute a takeover bid to purchase securities of CMB.TECH nor a solicitation by anyone in any jurisdiction with respect to CMB.TECH. The public takeover bid is only reopened on the basis of the supplement to the prospectus approved by the FSMA. Neither this notice nor any other information in respect of the matters contained herein may be supplied in any jurisdiction where a registration, qualification or any other obligation is in force or would be with regard to the content hereof or thereof. Any failure to comply with these restrictions may constitute a violation of the financial laws and regulations in such jurisdictions.

Additional Information for U.S. Holders

This press release is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell any ordinary shares, no par value, of CMB.TECH (“Ordinary Shares”) or any other securities.

The New U.S. Offer is only being made to U.S. Holders who are the beneficial owners of Ordinary Shares. The New U.S. Offer is made solely by the Offer to Purchase and related Letter of Transmittal, which are included in CMB’s Schedule TO filed with the U.S. Securities and Exchange Commission (SEC). The New U.S. Offer commences on October 23, 2024, and will expire at 10:00 A.M., New York City time, on November 21, 2024, unless the expiration of the New U.S. Offer is extended to a subsequent date in accordance with U.S. and Belgian law. U.S. Holders of Ordinary Shares tendering their Ordinary Shares will have withdrawal rights during this period as required by U.S. securities laws. U.S. Holders holding Ordinary Shares through a securities intermediary should comply with the dates communicated by such securities intermediary, as such dates may differ from the dates and times noted in the U.S. Offer to Purchase. U.S. Holders of Ordinary Shares are responsible for determining and complying with any applicable cut-off times and dates. Any U.S.

Regulated information

Holder of Ordinary Shares desiring to tender all or any portion of the Ordinary Shares owned by such U.S. Holder can accept the New U.S. Offer by (1) completing and signing a letter of transmittal (or a copy thereof, provided the signature is original) in accordance with the instructions in the letter of transmittal and mail or deliver it and all other required documents to the U.S. Tender Agent (as defined below), at the address on the back cover page of the Offer to Purchase or (2) tendering such Ordinary Shares pursuant to the procedures for book-entry transfer set forth in the Offer to Purchase. Any U.S. Holder of Ordinary Shares registered in the name of a broker, dealer, commercial bank, trust company or other nominee must contact such broker, dealer, commercial bank, trust company or other nominee if such

U.S. Holder desires to tender such Ordinary Shares.

CMB has retained Georgeson LLC to act as information agent for the New U.S. Offer and Computershare Trust Company, N.A., to act as depositary and paying agent for the New U.S. Offer (the “U.S. Tender Agent”).

Each Shareholder that is a U.S. Holder is urged to consult with his or her independent professional adviser regarding any acceptance of the New U.S. Offer including, without limitation, to consider the tax consequences associated with such Shareholder’s election to participate in the New U.S. Offer. No offer to acquire securities has been made, or will be made, directly or indirectly, in or into, or by the use of mails or any means of instrumentality of interstate or foreign commerce or any facilities of a national securities exchange of, the United States or any other country in which such offer may not be made other than (i) in accordance with the requirements of Regulations 14D and 14E under the Exchange Act or the securities laws of such other country, as the case may be or (ii) pursuant to an available exemption from such requirements. THE U.S. OFFER TO PURCHASE HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY STATE SECURITIES COMMISSION, NOR HAS THE SEC OR ANY STATE SECURITIES COMMISSION PASSED UPON THE FAIRNESS OR MERITS OF THE NEW U.S. OFFER OR UPON THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED IN THE U.S. OFFER TO PURCHASE. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL AND A CRIMINAL OFFENSE.

Shareholders that are U.S. Holders who wish to participate in the New U.S. Offer, are urged to read the tender offer statement on Schedule TO (including the offer to purchase, related letter of transmittal and certain other offer documents) that will be filed with the SEC by CMB and the related solicitation/recommendation statement on Schedule 14D-9 that will be filed with the SEC by CMB.TECH relating to the New U.S. Offer because such documents will contain important information that U.S. Holders should consider before making any decision with respect to the New U.S. Offer.

U.S. Holders may obtain a free copy of these documents after they have been filed with the SEC, and other documents filed by CMB and CMB.TECH with the SEC, at the SEC’s website at www.sec.gov, or by contacting Georgeson LLC, the information agent for the New U.S. Offer via telephone by calling +1 (888) 815-4069 for U.S. Holders or via +1 (781) 896- 6948 for shareholders outside the US, or via email to CMB.TECH@georgeson.com